SCHEMBL6537641

SCHEMBL6537641

CON(C)C(=O)c1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.54
KDM4E B2RXH2 3/20 0.54
TSHR P16473 2/20 0.54
TP53 P04637 6/20 0.46
MAPK1 P28482 2/20 0.46
USP2 O75604 1/20 0.46
RECQL P46063 1/20 0.46
PKM P14618 1/20 0.45
LMNA P02545 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
ALDH1A1 P00352 3/20 0.42
THRB P10828 1/20 0.42
POLB P06746 2/20 0.41
KMT2A Q03164 1/20 0.41
WDR5 P61964 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537716 0.87 HSD17B10 (0.52) HSD17B10KDM4ETSHRTP53MAPK1
SCHEMBL6537691 0.86 HSD17B10 (0.50) HSD17B10KDM4ETSHRTP53MAPK1
SCHEMBL6537601 0.86 HSD17B10 (0.49) HSD17B10KDM4ETSHRTP53MAPK1
SCHEMBL6538372 0.84 MAPK1 (0.66) HSD17B10KDM4ETSHRTP53MAPK1
SCHEMBL6537532 0.79 TP53 (0.51) HSD17B10KDM4ETSHRTP53MAPK1
SCHEMBL6537941 0.77 CSF1R (0.49) MAPK1USP2LMNAALDH1A1HTT
SCHEMBL6537773 0.75 LMNA (0.64) HSD17B10KDM4ETP53MAPK1USP2
SCHEMBL6537701 0.73 ALDH1A1 (0.43) HSD17B10KDM4ETSHRTP53LMNA
SCHEMBL6536422 0.72 TAS1R3 (0.45) HSD17B10KDM4ETSHRMAPK1LMNA
SCHEMBL6536826 0.72 HAVCR2 (0.45) TP53RXFP1POLBKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed